KALA Research and Charts

KALA - Kala Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2025-09-12)

Last 18.62	Change ⇑ +1.62 (+9.53%)	Volume 548,197
	Open 17.00	High 18.89	Low 16.90

8EMA (Daily) 15.35	40EMA (Daily) 10.40	50EMA (Daily) 9.68	STO (Daily) 89.920	MACD Hist (Daily) 1.153
8EMA (Weekly) 11.609	40EMA (Weekly) 7.38	50EMA (Weekly) 7.34	STO (Weekly) 95.953	MACD Hist (Weekly) 2.682


Company Profile
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye. The company's two marketed products are EYSUVIS and INVELTYS.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.